Natural killer (NK)-like T cells are major histocompatibility complex-unrestricted cytotoxic T cells that are surface CD3-positive, express NK-cell antigens, and rearrange their T-cell receptor. Most neoplasms arising from this T-cell subpopulation have been a chronic lymphoproliierative disease referred to as T-large granular lymphocyte (LGL) leukemia. Only 10 NK-like T-cell lymphomas have been described in detail previously; this study presents the clinicopathologic features of six others and distinguishes these lymphomas from T-LGL leukemia. All patients presented with B-symptoms and often had marked hepatosplenomegaly without significant peripheral lymphadenopathy. Four of the six patients were immunosuppressed. All had CD3, CD8, CD56-positive tumors, presumably of hepatosplenic (n = 3). intestinal (n = l), pulmonary (n = l), or nodal (n = 1) origin. Three patients had lymphomatous bone marrow infiltrates, and four had peripheral blood involvement by neoplastic large lymphocytes, some of which had a blastic appearance or ATURAL KILLER (NK)-like T cells are phenotypically mature T cells that have a large granular lymphocyte (LGL) morphology, express NK-cell antigens, and have properties similar to NK cells, such as cytotoxic activity in the absence of major histocompatibility complex antigen presentation.'" These NK-like T cells are surface CD3-positive and rearrange their T-cell receptor, either a, 5 or y6, which distinguishes them fmm true NK cell^.'^ NK-like T cells comprise less than 5% of human peripheral blood lymphocyte^,^^ and are distributed in the intestinal mucosa, particularly within the and in the hepatic sinusoids! Murine models also show NK-like T cells in the spleen?,"
NK-like T-cell neoplasms are usually considered a chronic lymphoproliferative disease, carrying the names Ty-lymphoproliferative disease, T-chronic lymphocytic leukemia, lymphoproliferative disorder of granular lymphocytes, and resembled virocytes. Azurophilic granules, ultrastructurally corresponding to cytoplasmic dense core andlor double density granules, were seen in all cases. T-cell d o n a l i was shown in five tumors by Southern blot analysis, and three had abnormal karyotypes. Two untreated patients died 20 days after presentation, and three patients who received combination chemotherapy died within 5 months of presentation. One patient remains in complete remission 22 months after treatment. These findings suggest NK-like Tcell lymphomas are aggressive, are clinicopathologically distinct from T-LGL leukemia, and should be in the differential diagnosis of extranodal T-cell lymphoproliferations, including those in immunosuppressed patients. Furthermore, the LGL morphology, phenotype, and tissue distribution of some NK-like T-cell lymphomas suggest they may arise from thymic-independent T cells of the hepatic sinusoids and intestinal mucosa. 0 1996 by The American Society of Hematology.
T-LGL leukemia.'' Patients with this disorder generally have a prolonged clinical course manifested by increased circulating CD57' T-LGLs, often with severe neutropenia, and occasionally have rheumatoid arthritis and mild to moderate ~plenornegaly.""~ On the other hand, only 10 apparent NKlike T-cell lymphomas have been described in detail.I4-*' Most of these present as aggressive CD56+ or CD57' hepatosplenic or intestinal tumors with variable nodal, cutaneous, and peripheral blood involvement. A recent description of three CD56+ aggressive variants of T-LGL leukemia may represent NK-like T-cell lymphomas with a leukemic phase."
In this report, we describe the clinical, morphologic, immunologic, karyotypic, and genotypic features of six NKlike T-cell lymphomas that distinguish these neoplasms as a clinicopathologic entity distinct from T-LGL leukemia. We also discuss the possibility that some of these NK-like Tcell lymphomas may arise from thymic-independent (extrathymically differentiated) T-cells.8,23
MATERIALS AND METHODS

Patient population.
Six patients with NK-like T-cell lymphomas, diagnosed at Vanderbilt University Medical Center (VUMC) since 1989, were included in this study. Four patients received their therapy at VUMC. Two others (patients 1 and 5), whose pathology materials were reviewed as Vanderbilt hematopathology consultation cases, were hospitalized elsewhere; their clinical data were retrieved through chart review and discussion with the referring pathologists.
Cytologic, histologic, and ultrastructural studies. Wright's stained films or touch imprints were evaluated from peripheral blood and aspirated bone marrow (patients 2 through 6), pleural fluid (patient 5 ) and resected tumors (patients l and 6). Neoplastic lymphocytes in patient peripheral blood films were compared with those from four patients with clonal T-LGL leukemia and from four patients known to have infectious mononucleosis. Differential counts of 200 hematopoietic cells were performed on marrow aspirate films for patients 2, 3, and 4. The morphological features on 4 pm thick, hematoxylin and eosin-, periodic acid-Schiff (PAS)-, and methyl green pyronin-stained sections of formalin-or B5-fixed, paraffin- . peripheral blood (patient 3), pleural fluid (patient 5), and lymph node (patients 5 and 6). Immunoalkaline phosphatase (IAP) studies using a labeled streptavidin-biotin system" (patients 3.4 and 5), and indirect immunofluorescence (IF)z6 (patients 1 through 4) were performed on cytocentrifuge preparations of cells suspended from the same tissues as those analyzed by flow cytometry (FACS). Paraffin immunoperoxidase (PIP) studies were performed on 4 pm sections of omental tumor (patient l), spleen (patient 2), bone marrow (patients 3 and 4), and lymph node (patients 5 and 6) using either a manual three-stage indirect immunoperoxidase technique" for monoclonal antibodies and an indirect peroxidase-antiperoxidase procedure** for polyclonal antibodies, or an avidin-biotin complex methodm with appropriate antigen retrieval using an automated immunostainer (Ventana 320 Automated Immunohistochemistry System, Ventana Medical Systems, Tuscon, M ) . DNA for molecular genetic analysis was isolated from omental tumor (patient l), bone marrow (patients 2 and 4), peripheral blood (patient 3), pleural fluid (patient 5), and lymph node (patient 6 ) using standard phenol-chloroform extraction. Purified DNA was digested with the restriction endonucleases BumHI, EcoR1, and H i d U and electrophoresed on agarose gels. The DNA was transferred to nylon membranes, and Southern blot analysis was performed as previously rep~rted.~.~' Blots were serially hybridized with probes for the Tcell receptor (TCR) beta-chain joining gene (JB) (Oncor, Gaithersburg, MD) in six patients, the TCR beta-chain constant gene (CB) For
RESULTS
Clinical features.
(fever, night sweats, weight loss). Most patients also had hepatosplenomegaly without significant peripheral lymphadenopathy and had an aggressive clinical course. Five patients were anemic, including patient 2 who presented with a Coombs'-positive hemolytic anemia. Three patients had an absolute lymphocytosis (range, 5,356 to 15,652/,uL) with rapidly rising counts in patients 2 and 4. Patient 3 had an absolute neutropenia that was associated with pneumonia. Four patients were chronically immunosuppressed for longstanding ulcerative colitis (patient 2) or after solid organ transplantation (patients 4, 5, and 6). Morphologic features. Peripheral blood involvement was extensive in patients 2, 3, and 4 and slight in patient 5. Circulating tumor cells were mostly large lymphocytes with abundant pale cytoplasm; fine to coarse azuropldic granulespersonal use only. on October 23, 2017. by guest www.bloodjournal.
org From
were seen in some neoplastic cells in all cases from films of peripheral blood, marrow, or pleural fluid, or from touch imprints of tumor (Fig 1A) . The neoplastic cells in patients 2 and 4 had oval nuclei with dispersed chromatin and prominent nucleoli ( Fig 1A) ; large cell size and a blastic appearance in some lymphocytes distinguished these neoplastic cells from those in patients with T-LGL leukemia (Fig I B) . Some tumor cells in patients 3 and 5 resembled "atypical" lymphocytes in patients with infectious mononucleosis; however, other neoplastic cells had increased nuclear to cytoplasmic ratios and markedly irregular nuclear profiles, which distinguished them from virocytes (Fig IC and D) . "Cloverleaf' peripheral blood tumor cells in patient 3 (Fig 2A) and markedly enlarged, dysplastic pleural fluid tumor cells in patient 5 (Fig 2B) demonstrated the extreme variability of nuclear shape and cell size.
Marrow involvement was more easily observed on films than in tissue sections. Differential counts on films from patients 2, 3, and 4 showed tumor cells comprised 59%. 28%. and 58% of marrow cells, respectively (Fig 3A) . On the other hand, sections showed only subtle interstitial lymphoid infiltrates without focal lesions in hypercellular marrows from each of these patients (Fig 3B) . Furthermore, erythrophagocytosis by tumor cells was readily identified in marrow films from patient 2, but was difficult to detect in splenic or marrow sections (Fig 3) .
The duodenal surface was ulcerated in patient I . Neoplastic lymphocytes filled the deeper lamina propria and focally infiltrated residual mucosal glands producing "lymphoepithelial" lesions ( Fig 4A) . Lymphoma cells in patient 1 and those that effaced the splenic architecture in patient 2 were medium-size in sections (Fig 4B) . Dys- plastic large lymphocytes effaced pulmonary hilar or mediastinal nodes in patients 5 and 6. They also infiltrated lung parenchyma, pleura, and pericardium in patient 5. Additionally, autopsy on patient 5 showed congestive hepatosplenomegaly (liver 2,240 g and splten 630 g) with erythrophagocytosis by histiocytes; no lymphoma was identified in the liver or spleen.
Electron microscopy demonstrated cytoplasmic dense core and/or double density granules (Fig 5 ) in some tumor cells from each patient studied. No parallel tubular arrays were found in obviously neoplastic cells. Immunologic features. Table 2 summari7~s the T-cell and NK-cell antigen expression of the tumor cells in each patient. The common phenotype was CD2', CD3+, CM-, CDS', CD56', and CD57-, and there was variable expression of other T-cell and NK-cell antigens. The tumor cells were phenotypically mature as there was no expression of CDI, CD10 or TdT. Tumors cells were CD45+, and none expressed CD15 or S-100. CD30 staining of tumor cells was seen only in patient 6. LMP staining was seen in most tumor cells from patients 1, 5, and 6, but was negative in patient 2.
Genetic features. Karyotypic and genotypic data are shown in Table 3 . Three of four patients studied had an abnormal karyotype. A t(2; 17) was observed in two analyzed cells from patient 3. Isochromosome 7q was present in I7 and 20 analyzed cells from patients 2 and 4, respectively. 
DISCUSSION
We have described six T-cell lymphomas whose LGL morphology, expression of CD3 and NK-cell antigens, and ability to rearrange their T-cell receptor indicate an origin from NK-like T cells. Ten other T-cell lymphomas with the features of NK-like T-cell lymphomas have been reported in detail (Table 4 ).14-*' Data from our series and the other case reports suggest these lymphomas are a separate clinicopathologic entity that can be distinguished from T-LGL leukemia by multiparametric analysis. In this combined series, NK-like T-cell lymphomas were aggressive as 93% presented with advanced stage disease and median survival was less than 6 months. The median age was 48 years (range, 9 to 66 years); five patients (3 1 %) were in the pediatric population. There was a 13:2 male:female ratio. Seventy-nine percent of patients presented with B-symptoms, and marked hepatosplenomegaly was common (60%). These lymphomas were usually extranodal (81%) and tended to be distributed in the liver, spleen, and marrow (50%) or in the gastrointestinal tract (25%). Nodal or cutaneous involvement without hepatosplenic or intestinal disease was unusual. A leukemic phase was common (63%) and developed after splenectomy in five of 10 patients. Peripheral white blood cell counts in patients with a leukemic phase had a median of 18,000/ pL (range, 3,000 to 203,0OO/pL). Thrombocytopenia was present in seven of 12 (58%) patients. A CD4-CD8+ phenotype was most common (n = 10) as compared with CD4+ CD8-(n = 2), CD4+ CD8' (n = 2) and CD4-CD8-(n = 2). CD56 was expressed on tumor cells in 11 of 12 (92%) lymphomas studied for this antigen, whereas CD57 positivity was observed in only four of 15 (27%) cases. Aberrant chromosomal analyses were found in five of six lymphomas studied, and four of these had an i(7q).
Clinical implications dictate distinguishing leukemic involvement by NK-like T-cell lymphomas from the more indolent T-LGL leukemia. In comparison with T-LGL leukemia, patients with NK-like T-cell lymphomas are more likely to be within the pediatric population, to present with Bsymptoms and marked hepatosplenomegaly, and to have thrombocytopenia and a rapid increase in the number of leukemic cells."-21 NK-like T-cell lymphomas have less frequent neutropenia and infections. Leukemic cells of NK-like T-cell lymphomas often exhibit marked nuclear pleomorphism or have a blastic appearance, the latter being rare in chronic LGL leukemias.34 There is a greater tendency for NK-like T-cell lymphomas to express CD56 rather than CD57, whereas the opposite has been reported for T-LGL leukemia." Parallel tubular arrays, frequently seen in ultrastructural studies of T-LGL are apparently uncommon among NK-like T-cell lymphomas (seen in two of 11 cases studied). Cytogenetic abnormalities are common in NK-like T-cell lymphomas, but not in T-LGL leukemia." These differences between the two groups of neoplasms indicate that the recently reported cases of CD56+ aggressive variant of T-LGL leukemia" may be NK-like T-cell lymphomas with a leukemic phase.
Several features seen in our series of NK-like T-cell lymphomas may have biologic and clinical significance; in particular, CD56 (NCAM) expression, chromosomal abnormalities, immunosuppression, and EBV infection are noteworthy. NCAM, a neural cell adhesion molecule involved in homotypic interactions, has been implicated in the extranodal dissemination of some peripheral T-cell lymphomas (PTCLs), and its expression has been associated with an aggressive clinical course.'y,36.37 However, some lymphomas regarded as NCAM-positive PTCLs may be true NK-cell lymphomas rather than NK-like T-cell lymphoma^.^^ Therefore, the term NK-like T-cell lymphoma might be best reserved for those lymphomas that express surface CD3 (or framework determinants of the TCR) and NK-cell antigens, particularly CD56, and have cytoplasmic granules by light or electron microscopy. NK-like T-cell lymphomas that lack surface CD3 or TCR framework determinants should exhibit TCR gene rearrangements to distinguish them from true NKcell lymphomas.
Chromosomal abnormalities in NK-like T-cell lymphomas may be of pathogenetic and prognostic significance. For instance, the erythrophagocytic T-cell lymphoma in patient 2 had a t(8; 14)(q24;q24), which may have juxtaposed the cmyc gene on 8q2438 and a transcriptionally active (housekeeping) cytoskeletal protein gene such as that for aactinin located on 14q24.39 Deregulation of c-myc, seen in some T-cell neoplasms,m as well as possible alterations in the quantity and cellular localization of cytoskeletal components may have contributed to malignant tran~formation.4"~~ Furthermore, altered cytoskeletal proteins may have permitted the phagocytosis of IgG-coated erythrocytes by the tumor cells in this patient, a function not normally ascribed to T cells. From a prognostic standpoint, total or partial trisomy 7q, as produced by i(7q) in patients 2 and 4 and in two others with an NK-like T-cell lymphoma20.21 and a high proportion of abnormal metaphases, also in patients 2 and 4, are significantly more frequent in high-grade than in lowgrade F'TCLs.@
The roles of immunosuppression and EBV infection in NKlike T-cell lymphomas are unclear. Four patients in our series were chronically immunosuppressed, including three who had received solid organ transplants. Therefore, NK-like T-cell lymphomas should be included in the differential diagnosis of T-cell proliferations developing in immunosuppressed patients. It is also interesting that two of our posttransplant patients and another with an intestinal NK-like T-cell lymphoma had smng LMP immunopositivity in nearly all tumor cells, suggesting they were EBV-as~ociated."~ However, it remains to be determined whether EBV is a pathogenetic,factor in the development of NK-like T-cell lymphomas, or if infection of the tumor cells occurs after clonal expansion.
Of further biologic interest is the observation that hepatosplenic and intestinal NK-like T-cell lymphomas not only have cytological (LGL morphology) and immunological (CD56+ or CD57+) features in common with thymic-independent T cells, but also have similar tissue distributions.n,z3,46-4~ NK-like T-cell lymphomas also may be of ap or yS" types, as are extrathymically derived Furthermore, thymic-independent T cells may be CD4-CD8+, CD4' CDK, CD4+ CD8+, or CD4-CD8-n,2334y; as noted above, all four of these phenotypes have been observed among NK-like T-cell lymphomas. Therefore, it is possible that these lymphomas are derived from T-cell subpopulations with extrathymic pathways of differentiation.
Finally, NK-like T-cell lymphomas should be considered for all lymphomas of presumed hepatosplenic and intestinal origin if patients present with B-symptoms and advanced stage disease, including a leukemic phase. We recommend, in agreement with Warzynski et al,2' multiparametric analysis, as described below, to facilitate recognition of these aggressive lymphomas. Cytoplasmic granules may be demonstrated in tumor cells using Romanovsky's-type stains on peripheral blood, marrow, or other body fluid films or on touch imprints of tumors. Electron microscopy may be used to detect granules not seen by light microscopy. Immunophenotypic analysis should include a broad panel of T-cell and NK-cell antigens (see Table 2 ). Cytogenetic analysis may pinpoint patients with especially poor prognosis, as well as identify specific chromosomal abnormalities. T-cell receptor gene rearrangement studies are recommended to prove clonality in morphologically difficult lesions and to distinguish some NK-like Tcell lymphomas from true NK-cell lymphomas.
NOTE ADDED IN PROOF
Dr Mohamed Elkhalifa, Director of Hematopathology, University of South Alabama, Mobile, Alabama, has kindly provided us data and patient materials on another NK-like T-cell lymphoma since this manuscript was prepared. The patient was a 62-year-old female who presented with Bsymptoms, hepatosplenomegaly, abdominal pain, and slight lymphadenopathy. Peripheral blood (WBC = 55 X 103/pL with 80% lymphocytes, hematocrit = 31.6%, and platelets = 20 X 103/pL), bone marrow and a submental lymph node were involved by lymphoma that was CD2+, CD3', CD4-, CDY, CD7+, CD8-, CDllb+, CDllc-, CD16+, CD56', CD57-, CD45RO', PFIC, and L W + . The T-cell receptor beta chain gene was rearranged. There was an abnormal karyotype, including an i(7q). The patient died two months after presentation despite combination chemotherapy (CHOP).
